5th Annual MarketsandMarkets(MnM) Orphan Drugs and Rare Diseases Conference

5th Annual MarketsandMarkets Orphan Drugs and Rare Diseases Conference is organized by MarketsandMarkets Conferences and will be held from Oct 14 - 15, 2024 at Freiburg Im Breisgau, Baden-Wurttemberg, Germany.

Key Highlights:
• Overview and Regulatory Updates: Current Landscape and Regulatory Developments in EU Market
• Emerging Therapies for RDs: Gene Editing, Cell & Gene Therapies, Regenerative Therapies.
• Rare Disease Diagnostics & Care: Novel Methods, Biomarker Discovery, AI/ML, and Genetic Testing Technologies for Early Detection and Monitoring.
• Rare Disease Genetics and Genomics: Unveiling Rare Genetic Disease Mechanisms and Therapeutic Targets
• Patient Advocacy, Engagement & Collaboration: Role Patient Advocacy and Global Collaboration in Research and Development.
• Health Economics & Market Access: Barriers to market access for orphan drugs and strategies ensuring patient affordability and accessibility.
• Drug Discovery & Clinical Trial design: Novel drug discoveries and clinical trial methods for rare diseases.
• Uncommon genetic conditions: Recent Advancements in gene therapy and personalized therapies for rare genetic disorders.
• Pricing, Reimbursement & HTA: Health Technology Assessment on decision-making, challenges on high pricing, and reimbursement negotiations.
• Paediatric Rare Diseases: Emerging Therapies and Distinctive Obstacles in the Identification, Therapy, and Sustained Care of rare diseases in children.
• Ethical and Legal Considerations: Ethical dilemmas, patient privacy concerns, and legal issues surrounding rare disease research, and data sharing.

Why Attend:
• Hear from influential keynote speakers who share their experiences, insights, and visions for the future.
• Get access to the latest research findings, innovative therapies, and breakthroughs in the field.
• Platform to exchange insights, discoveries, and best practices in the realm of orphan drugs and rare diseases.
• Participate in discussions with experts on how to tackle the critical issues shaping the future of orphan drugs.
• Discover and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
• Gain awareness about rare diseases and the challenges associated with developing treatments for these conditions.
• Collaboration & Networking Opportunities between academia, industry, and advocacy groups, fostering partnerships aimed at accelerating research, drug development, and access to therapies for rare diseases.